Production and characterization of a novel long-acting Herceptin-targeted nanobubble contrast agent specific for Her-2-positive breast cancers

BACKGROUND: There is an unmet need for specific and sensitive imaging techniques to assess the efficacy of breast cancer therapy, particularly Her-2-expressing cancers. Ultrasonic microbubbles are being developed for use as diagnostic and therapeutic tools. However, nanobubbles circulate longer, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Qiongchao, Hao, Shaoyun, Xiao, Xiaoyun, Yao, Jiyi, Ou, Bing, Zhao, Zizhuo, Liu, Fengtao, Pan, Xin, Luo, Baoming, Zhi, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839059/
https://www.ncbi.nlm.nih.gov/pubmed/25691133
http://dx.doi.org/10.1007/s12282-014-0581-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839059/
https://www.ncbi.nlm.nih.gov/pubmed/25691133
http://dx.doi.org/10.1007/s12282-014-0581-8

Ejemplares similares